Hemic and Immune Systems: News and Research on Intraepithelial Lymphocytes

First-in-human immunotherapy more than doubles progression-free survival in glioblastoma patients

Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat because of limited treatment options and a poor prognosis. Patient outcomes have remained largely unchanged ...